Pelvic Organ Prolapse (POP)

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Cosm Medical
Cosm MedicalON - Toronto
1 program
Novel Personalizable PessaryN/A1 trial
Active Trials
NCT06954701Not Yet RecruitingEst. Oct 2026
C
ColoplastAustralia - Mulgrave
1 program
Restorelle Direct Fix A&PN/A1 trial
Active Trials
NCT01378065CompletedEst. Sep 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cosm MedicalNovel Personalizable Pessary
ColoplastRestorelle Direct Fix A&P

Clinical Trials (2)

NCT06954701Cosm MedicalNovel Personalizable Pessary

Evaluation of a Personalizable Pessary for Pelvic Organ Prolapse

Start: Feb 2026Est. completion: Oct 2026
N/ANot Yet Recruiting
NCT01378065ColoplastRestorelle Direct Fix A&P

Restorelle Direct Fix Anterior and Posterior (A&P) for Female Pelvic Organ Prolapse: A Prospective Post Market Study

Start: Jun 2011Est. completion: Sep 2013
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space